Literature DB >> 1716027

Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates.

L M Williams1, M W Cloyd.   

Abstract

Independent isolates of HIV-1 differ widely in their tropisms for CD4-positive T-cell lines. This study demonstrates that tropisms of 10 different HIV-1 isolates also differ widely, as much as 1000-fold, for normal peripheral blood lymphocytes (PBLs) cultured from any given donor. This could only be reproducibly demonstrated by end point titrations. In addition, the degree of susceptibility of PBLs from 12 random donors to productive infection by any given HIV-1 isolate also varied in a reproducible pattern from donor to donor, with some donors relatively resistant to one or a few isolates. The HIV susceptibility pattern of each donor was manifested at the level of the CD4 lymphocyte and it segregated within a family, conclusively demonstrating that it was genetically determined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716027     DOI: 10.1016/0042-6822(91)90442-e

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  A conserved mechanism of retrovirus restriction in mammals.

Authors:  G Towers; M Bock; S Martin; Y Takeuchi; J P Stoye; O Danos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.

Authors:  C Neuveut; K T Jeang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group.

Authors:  W A Scott; D Brambilla; E Siwak; C Beatty; J Bremer; R W Coombs; H Farzadegan; S A Fiscus; S M Hammer; F B Hollinger; N Khan; S Rasheed; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 4.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  How does HIV-1 infect a susceptible human cell?: Current thinking.

Authors:  Ali A Al-Jabri
Journal:  J Sci Res Med Sci       Date:  2003-08

6.  Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression.

Authors:  Gabriela Bleiber; Margaret May; Raquel Martinez; Pascal Meylan; Jürg Ott; Jacques S Beckmann; Amalio Telenti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.

Authors:  Ana M Sanchez; C Todd DeMarco; Bhavna Hora; Sarah Keinonen; Yue Chen; Christie Brinkley; Mars Stone; Leslie Tobler; Sheila Keating; Marco Schito; Michael P Busch; Feng Gao; Thomas N Denny
Journal:  J Immunol Methods       Date:  2014-01-19       Impact factor: 2.303

8.  The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection.

Authors:  J D Lifson; M A Nowak; S Goldstein; J L Rossio; A Kinter; G Vasquez; T A Wiltrout; C Brown; D Schneider; L Wahl; A L Lloyd; J Williams; W R Elkins; A S Fauci; V M Hirsch
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro.

Authors:  J Chang; H M Naif; S Li; J S Sullivan; C M Randle; A L Cunningham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

10.  Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.

Authors:  L Rabin; M Hincenbergs; M B Moreno; S Warren; V Linquist; R Datema; B Charpiot; J Seifert; H Kaneshima; J M McCune
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.